Inventor · disambiguated record
Robert Kevin Perrone
Also filed as: PERRONE ROBERT K · PERRONE ROBERT KEVIN
11 granted patents·6 pending applications·176 citations·filing 1986–2013
90Inventor score
Files withBRISTOL MYERS SQUIBB CO8BRISTOL MYERS CO2PERRONE ROBERT KEVIN2CHANDRAN SACHIN1CHIDAMBARAM RAMAKRISHNAN1
Top patents by PatentIndex Score
17 records- 0189US5646176APhosphonooxymethyl ethers of taxane derivativesBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Jul 8, 1997·104 cites·43 claims
- 0283US8338606B2Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamidePERRONE ROBERT KEVIN·Filed 2012·Granted Dec 25, 2012·10 cites·11 claims
- 0380US8202996B2Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N- ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamidePERRONE ROBERT KEVIN·Filed 2008·Granted Jun 19, 2012·6 cites·12 claims
- 0452US6207650B1Antiviral, highly water soluble, stable, crystalline salts of 2′, 3′-dideoxyinosine, 2′, 3′-dideoxy-2′, 3′-didehydrothymidine and 2′, 3′-dideoxy-2′-fluoroinosineBRISTOL MYERS SQUIBB CO·Filed 1991·Granted Mar 27, 2001·7 cites·24 claims
- 0551US4772589AEtoposide solution in NMPBRISTOL MYERS CO·Filed 1986·Granted Sep 20, 1988·14 cites·10 claims
- 0650US5608048Ad4 T polymorphic Form 1 processBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Mar 4, 1997·9 cites·5 claims
- 0750US2004122081A1Pharmaceutical compositions and methods of using taxane derivativesFiled 2003·Application pending·0 cites
- 0850US2005054716A1Pharmaceutical compositions and methods of using taxane derivativesFiled 2003·Application pending·0 cites
- 0946US5196555AWater and solvent soluble axial hydroxy and mono- and di- carboxylic acid derivatives having high tumor activityBRISTOL MYERS SQUIBB CO·Filed 1991·Granted Mar 23, 1993·4 cites·17 claims
- 1044US5455270AStabilized solutions of platinum(II) antitumor agentsBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Oct 3, 1995·13 cites·16 claims
- 1142US2013302414A1Solubilized capsule formulation of 1,1-dimethylethyl [(1s)-1-carbamoyl)pyrrolidin-1-yl]carbonyl}-2,2-dimethylpropyl]carbamateBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 1241US2003220391A1Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailabilityFiled 2002·Application pending·0 cites
- 1340US6455575B2Phosphonooxymethyl ethers of taxane derivativesBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Sep 24, 2002·7 cites·38 claims
- 1440US2006116420A1Crystalline forms of 3'-tert-Butyl-3'-N-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-N-debenzoyl-4-O-methoxycarbonyl-paclitaxelCHIDAMBARAM RAMAKRISHNAN·Filed 2005·Application pending·0 cites
- 1538US2015119317A1Oral solid dosage formulation of 1,1-dimethylethyl [(1s)-1-carbamoyl)pyrrolidin-1-yl]carbonyl}-2,2-dimethylpropyl]carbamateBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 1630US4946689AConcentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatinBRISTOL MYERS CO·Filed 1988·Granted Aug 7, 1990·2 cites·2 claims
- 1729US8252821B2Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compoundCHANDRAN SACHIN·Filed 2010·Granted Aug 28, 2012·0 cites·30 claims
Join the waitlist — get patent alerts
Get an alert when Robert Kevin Perrone files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →